Figure 1.

Gain Therapeutics, Inc.

Change in MDS-UPDRS scores from Baseline at Day 150 in all patients for whom CSF GluSph were available, patients with low baseline GluSph, and patients with high baseline GluSph

Format

JPEG

Source

Gain Therapeutics, Inc.

Downloads